Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC
Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC
1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses
2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer
Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases
Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma
Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations
Durvalumab after SBRT reduces tumour progression in early-stage NSCLC
Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS benefit but is safe
Transforming radiotherapy skin care by recognising diverse skin reactions
Improving African representation in breast cancer genomics
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT